journal article Open Access Oct 09, 2011

An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation

Topics

No keywords indexed for this article. Browse by subject →

References
41
[1]
Erpenbeck, V.J. et al. Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes. J. Allergy Clin. Immunol. 111, 1319–1327 (2003). 10.1067/mai.2003.1485
[2]
Shimbara, A. et al. IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma. J. Allergy Clin. Immunol. 105, 108–115 (2000). 10.1016/s0091-6749(00)90185-4
[3]
White, B., Leon, F., White, W. & Robbie, G. Two first-in-human, open-label, phase I dose-escalation safety trials of MEDI-528, a monoclonal antibody against interleukin-9, in healthy adult volunteers. Clin. Ther. 31, 728–740 (2009). 10.1016/j.clinthera.2009.04.019
[4]
Temann, U.A., Laouar, Y., Eynon, E.E., Homer, R. & Flavell, R.A. IL9 leads to airway inflammation by inducing IL13 expression in airway epithelial cells. Int. Immunol. 19, 1–10 (2007). 10.1093/intimm/dxl117
[5]
Temann, U.A., Geba, G.P., Rankin, J.A. & Flavell, R.A. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J. Exp. Med. 188, 1307–1320 (1998). 10.1084/jem.188.7.1307
[6]
Temann, U.A., Ray, P. & Flavell, R.A. Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. J. Clin. Invest. 109, 29–39 (2002). 10.1172/jci0213696
[7]
Cheng, G. et al. Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model. Am. J. Respir. Crit. Care Med. 166, 409–416 (2002). 10.1164/rccm.2105079
[8]
Kung, T.T. et al. Effect of anti-mIL-9 antibody on the development of pulmonary inflammation and airway hyperresponsiveness in allergic mice. Am. J. Respir. Cell Mol. Biol. 25, 600–605 (2001). 10.1165/ajrcmb.25.5.4533
[9]
Townsend, J.M. et al. IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 13, 573–583 (2000). 10.1016/s1074-7613(00)00056-x
[10]
Kearley, J. et al. IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways. Am. J. Respir. Crit. Care Med. 183, 865–875 (2010). 10.1164/rccm.200909-1462oc
[11]
Wynn, T.A. IL-13 effector functions. Annu. Rev. Immunol. 21, 425–456 (2003). 10.1146/annurev.immunol.21.120601.141142
[12]
Cho, J.Y. et al. Inhibition of airway remodeling in IL-5-deficient mice. J. Clin. Invest. 113, 551–560 (2004). 10.1172/jci19133
[13]
Faulkner, H., Renauld, J.C., Van Snick, J. & Grencis, R.K. Interleukin-9 enhances resistance to the intestinal nematode Trichuris muris. Infect. Immun. 66, 3832–3840 (1998). 10.1128/iai.66.8.3832-3840.1998
[14]
Faulkner, H., Humphreys, N., Renauld, J.C., Van Snick, J. & Grencis, R. Interleukin-9 is involved in host protective immunity to intestinal nematode infection. Eur. J. Immunol. 27, 2536–2540 (1997). 10.1002/eji.1830271011
[15]
Richard, M., Grencis, R.K., Humphreys, N.E., Renauld, J.C. & Van Snick, J. Anti-IL-9 vaccination prevents worm expulsion and blood eosinophilia in Trichuris muris-infected mice. Proc. Natl. Acad. Sci. USA 97, 767–772 (2000). 10.1073/pnas.97.2.767
[16]
Angkasekwinai, P., Chang, S.H., Thapa, M., Watarai, H. & Dong, C. Regulation of IL-9 expression by IL-25 signaling. Nat. Immunol. 11, 250–256 (2010). 10.1038/ni.1846
[17]
Chang, H.C. et al. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat. Immunol. 11, 527–534 (2010). 10.1038/ni.1867
[18]
Staudt, V. et al. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33, 192–202 (2010). 10.1016/j.immuni.2010.07.014
[19]
Veldhoen, M. et al. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9, 1341–1346 (2008). 10.1038/ni.1659
[20]
Gounni, A.S. et al. IL-9 expression by human eosinophils: regulation by IL-1beta and TNF-alpha. J. Allergy Clin. Immunol. 106, 460–466 (2000). 10.1067/mai.2000.109172
[21]
Hültner, L. et al. In activated mast cells, IL-1 up-regulates the production of several Th2-related cytokines including IL-9. J. Immunol. 164, 5556–5563 (2000). 10.4049/jimmunol.164.11.5556
[22]
Stassen, M. et al. Murine bone marrow-derived mast cells as potent producers of IL-9: costimulatory function of IL-10 and kit ligand in the presence of IL-1. J. Immunol. 164, 5549–5555 (2000). 10.4049/jimmunol.164.11.5549
[23]
Fallon, P.G. et al. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J. Exp. Med. 203, 1105–1116 (2006). 10.1084/jem.20051615
[24]
Hurst, S.D. et al. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J. Immunol. 169, 443–453 (2002). 10.4049/jimmunol.169.1.443
[25]
Fort, M.M. et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15, 985–995 (2001). 10.1016/s1074-7613(01)00243-6
[26]
Saenz, S.A. et al. IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature 464, 1362–1366 (2010). 10.1038/nature08901
[27]
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

Daniel R. Neill, See Heng Wong, Agustin Bellosi et al.

Nature 2010 10.1038/nature08900
[28]
Moro, K. et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells. Nature 463, 540–544 (2010). 10.1038/nature08636
[29]
Systemically dispersed innate IL-13–expressing cells in type 2 immunity

April E. Price, Hong-Erh Liang, Brandon M. Sullivan et al.

Proceedings of the National Academy of Sciences 2010 10.1073/pnas.1003988107
[30]
Spits, H. & Di Santo, J.P. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat. Immunol. 12, 21–27 (2011). 10.1038/ni.1962
[31]
Tan, C. et al. Antigen-specific Th9 cells exhibit uniqueness in their kinetics of cytokine production and short retention at the inflammatory site. J. Immunol. 185, 6795–6801 (2010). 10.4049/jimmunol.1001676
[32]
Novey, H.S., Marchioli, L.E., Sokol, W.N. & Wells, I.D. Papain-induced asthma–physiological and immunological features. J. Allergy Clin. Immunol. 63, 98–103 (1979). 10.1016/0091-6749(79)90198-2
[33]
Sokol, C.L., Barton, G.M., Farr, A.G. & Medzhitov, R. A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat. Immunol. 9, 310–318 (2008). 10.1038/ni1558
[34]
Oboki, K. et al. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc. Natl. Acad. Sci. USA 107, 18581–18586 (2010). 10.1073/pnas.1003059107
[35]
Wang, Y.H. et al. A novel subset of CD4+ T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J. Exp. Med. 207, 2479–2491 (2010). 10.1084/jem.20101376
[36]
Hirota, K. et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12, 255–263 (2011). 10.1038/ni.1993
[37]
Houssiau, F.A. et al. A cascade of cytokines is responsible for IL-9 expression in human T cells. Involvement of IL-2, IL-4, and IL-10. J. Immunol. 154, 2624–2630 (1995). 10.4049/jimmunol.154.6.2624
[38]
Houssiau, F.A., Renauld, J.C., Fibbe, W.E. & Van Snick, J. IL-2 dependence of IL-9 expression in human T lymphocytes. J. Immunol. 148, 3147–3151 (1992). 10.4049/jimmunol.148.10.3147
[39]
Belyaev, N.N. et al. Induction of an IL7-R+c-Kit(hi) myelolymphoid progenitor critically dependent on IFN-γ signaling during acute malaria. Nat. Immunol. 11, 477–485 (2010). 10.1038/ni.1869
[40]
Chang, Y.J. et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat. Immunol. 12, 631–638 (2011). 10.1038/ni.2045
[41]
Steenwinckel, V. et al. IL-9 promotes IL-13-dependent paneth cell hyperplasia and up-regulation of innate immunity mediators in intestinal mucosa. J. Immunol. 182, 4737–4743 (2009). 10.4049/jimmunol.0801941
Cited By
421
International Forum of Allergy &amp...
Nature Communications
Journal of Experimental Medicine
Journal of Experimental Medicine
Frontiers in Immunology
Nature Reviews Immunology
Immunity
The immunology of asthma

Bart N Lambrecht, HAMIDA HAMMAD · 2014

Nature Immunology
Type 2 Innate Lymphoid Cells Drive CD4+ Th2 Cell Responses

Ananda S Mirchandani, Anne-Gaelle Besnard · 2014

The Journal of Immunology
Nature Reviews Immunology
TH2, allergy and group 2 innate lymphoid cells

Paula Licona-Limón, Lark Kyun Kim · 2013

Nature Immunology
Nature Reviews Immunology
Essentials of Th17 cell commitment and plasticity

Pawel Muranski, Nicholas P. Restifo · 2013

Blood
Journal of Allergy and Clinical Imm...
Metrics
421
Citations
41
References
Details
Published
Oct 09, 2011
Vol/Issue
12(11)
Pages
1071-1077
License
View
Cite This Article
Christoph Wilhelm, Keiji Hirota, Benjamin Stieglitz, et al. (2011). An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nature Immunology, 12(11), 1071-1077. https://doi.org/10.1038/ni.2133
Related

You May Also Like

Cancer immunoediting: from immunosurveillance to tumor escape

Gavin P. Dunn, Allen T. Bruce · 2002

4,170 citations

Innate and adaptive immune cells in the tumor microenvironment

Thomas F Gajewski, Hans Schreiber · 2013

3,521 citations

T cell exhaustion

E John Wherry · 2011

3,513 citations